A carregar...

Sclerostin Inhibition in the Management of Osteoporosis

The recognition of the importance of the Wnt-signaling pathway in bone metabolism and studies of patients with rare skeletal disorders characterized by high bone mass identified sclerostin as target for the development of new therapeutics for osteoporosis. Findings in animals and humans with scleros...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Calcif Tissue Int
Main Authors: Appelman-Dijkstra, Natasha M., Papapoulos, Socrates E.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4824823/
https://ncbi.nlm.nih.gov/pubmed/27016922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00223-016-0126-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!